Cartesian Therapeutics Announces Board and Executive Changes
Ticker: RNAC · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, compensation
TL;DR
Board shakeup and comp changes at Cartesian Therapeutics.
AI Summary
On October 15, 2025, Cartesian Therapeutics, Inc. reported changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory plans.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal shifts that may affect future performance and stability.
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Registrant
- October 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Frederick, MD (location) — Principal executive offices
FAQ
What specific roles have seen departures or appointments?
The filing indicates departures of certain officers and directors, and the election of new directors, but does not specify individual roles in this excerpt.
When was the earliest event reported in this filing?
The earliest event reported was on October 15, 2025.
What is the principal executive office address for Cartesian Therapeutics, Inc.?
The principal executive office is located at 7495 New Horizon Way, Frederick, MD 21703.
What is the company's state of incorporation?
Cartesian Therapeutics, Inc. is incorporated in Delaware.
What is the IRS Employer Identification Number (EIN) for Cartesian Therapeutics, Inc.?
The IRS Employer Identification Number is 26-1622110.
Filing Stats: 598 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-10-21 07:00:09
Key Financial Figures
- $0.0001 — ich registered Common Stock (Par Value $0.0001) RNAC The Nasdaq Stock Market LLC Ind
Filing Documents
- rnac-20251015.htm (8-K) — 27KB
- 0001453687-25-000106.txt ( ) — 140KB
- rnac-20251015.xsd (EX-101.SCH) — 2KB
- rnac-20251015_lab.xml (EX-101.LAB) — 21KB
- rnac-20251015_pre.xml (EX-101.PRE) — 12KB
- rnac-20251015_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CARTESIAN THERAPEUTICS, INC. Date: October 21, 2025 By: /s/ Carsten Brunn, Ph.D. Carsten Brunn, Ph.D. President and Chief Executive Officer